Jennitte Stevens
Amgen (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality(2012)402 cited
- → A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair(2016)251 cited
- → Transcription Control by E1A and MAP Kinase Pathway via Sur2 Mediator Subunit(2002)237 cited
- → AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer(2020)225 cited
- → Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex(2012)211 cited
- → Mediator Requirement for Both Recruitment and Postrecruitment Steps in Transcription Initiation(2005)202 cited
- → Fibroblast Growth Factor 23 (FGF23) and Alpha-Klotho Stimulate Osteoblastic MC3T3.E1 Cell Proliferation and Inhibit Mineralization(2011)162 cited
- → FGF21 N‐ and C‐termini play different roles in receptor interaction and activation(2008)149 cited
- → Co-receptor Requirements for Fibroblast Growth Factor-19 Signaling(2007)138 cited
- → Expression of Cytochrome P450 Genes of the CYP4 Family in Midgut and Fat Body of the Tobacco Hornworm, Manduca sexta(1995)136 cited